Hydroxychloroquine for early Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether hydroxychloroquine, a medicine used for other conditions, can help people with early Parkinson's disease. It aims to see if the drug is safe and can slow down the progression of symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 80 years old.
- You have been diagnosed with Parkinson's disease for at least 6 months but no more than 4 years.
- Your symptoms are mild (you can still walk and balance well).
- You have been on the same Parkinson's medications for at least 30 days and are not expected to need changes for about a year.
- You have no severe movement problems or disabling involuntary movements.
- You are not taking certain medicines (like antipsychotics or antimalarials) and have no history of psoriasis, porphyria, or eye problems.
- You are willing to use effective birth control if you are sexually active.
- You have not had major surgery recently or planned, and you are generally healthy.
- You have not participated in another drug trial in the last 3 months, and you are not planning deep brain stimulation or similar procedures.
- Your kidney and liver function are within normal limits, and you have no history of blood disorders or G6PD deficiency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medicine, GT-02287, to see if it can help people with early Parkinson's disease. It aims to improve symptoms and slow the disease, and it also tracks how the medicine affects certain markers in the body.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
This trial tests an experimental drug called RO7568282 to see if it is safe and can help with early Parkinson's disease symptoms. It is for people who have been taking a stable dose of levodopa alone for at least two months.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
This trial tests a new oral medication, VG081821AC, in people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement symptoms and slow the progression of the condition, and it may offer a new treatment option for those not yet on levodopa.
Hear when a new Parkinson&Amp;#39;s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.